Private equity has been buying up hospice centers — with striking consequences
Source Entity
Jessica Hall

New research reveals that hospice centers acquired by private equity firms are associated with longer patient stays and higher Medicare costs. These findings highlight the financial and operational shifts occurring as private investors increase their footprint in end-of-life care.
The Financialization of End-of-Life Care
Recent research has shed light on a significant shift in the healthcare landscape: the increasing acquisition of hospice centers by private equity (PE) firms. While hospice care is intended to provide comfort and dignity in the final stages of life, the entry of profit-driven investment models into this sector has sparked critical questions regarding the quality and cost-effectiveness of these services. The data indicates a clear trend where facilities under PE ownership exhibit distinct operational patterns compared to their non-profit or independent counterparts.
Escalating Medicare Expenditures
The most striking finding is the correlation between private equity ownership and increased Medicare costs. As these firms seek to maximize returns on their investments, the financial structures of the hospice centers they acquire appear to result in higher billing to the federal government. This inflationary pressure on Medicare represents a broader concern for public health policy, as the sustainability of the hospice benefit relies on the efficient and ethical use of taxpayer funds. When profit margins become a primary driver, the systemic cost of end-of-life care inevitably rises.
The Dynamics of Longer Patient Stays
Beyond simple costs, the research highlights that patients at PE-owned hospice centers tend to have longer stays. In a clinical context, the duration of hospice care is often a balance between providing necessary support and ensuring that patients meet the medical criteria for end-of-life services. Longer stays, while potentially beneficial if they reflect better access to care, raise questions about whether these metrics are being manipulated to extend billing cycles. This shift in patient duration suggests a fundamental change in how hospice providers manage their census and service delivery models.
Broader Implications for Healthcare Quality
The involvement of private equity in healthcare has long been a subject of intense debate. Unlike traditional healthcare providers, which are often mission-driven, private equity firms operate on a timeline focused on short-term value creation and exit strategies. When applied to hospice, a sector that requires deep compassion and specialized palliative care, this model may create a misalignment of incentives. The core mission of hospice—to prioritize patient comfort over aggressive medical interventions—could be at risk if operational efficiency is prioritized over patient-centered outcomes.
Historical Context and Future Trends
Historically, hospice care was dominated by non-profit organizations and hospital-based programs. However, the consolidation of the market by private equity marks a departure from this legacy. Looking forward, the healthcare industry may face increased regulatory scrutiny as lawmakers examine the impact of these ownership structures on the Medicare system. Future trends likely include more rigorous oversight of hospice billing practices and a potential push for greater transparency regarding the ownership and operational performance of hospice providers to ensure that patient care remains the paramount concern.
Verification Required?